Jun 5 |
Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion
|
Jun 4 |
KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic
|
May 14 |
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
|
May 3 |
It Looks Like KORU Medical Systems, Inc.'s (NASDAQ:KRMD) CEO May Expect Their Salary To Be Put Under The Microscope
|
May 2 |
KORU Medical Systems Inc (KRMD) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ...
|
May 2 |
KORU Medical Systems, Inc. (KRMD) Q1 2024 Earnings Call Transcript
|
May 1 |
KORU Medical Systems Inc (KRMD) Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Challenges
|
May 1 |
KORU Medical Systems GAAP EPS of -$0.04 in-line, revenue of $8.2M beats by $0.67M
|
May 1 |
KORU Medical Systems, Inc. 2024 Q1 - Results - Earnings Call Presentation
|
May 1 |
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth
|